Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
William Shatner Explains Why His Gremlin ‘Twilight Zone’ Episode Remains So Iconic 63 Years Later
"Nightmare at 20,000 Feet" remains one of the most recognizable episodes of Rod Serling's 'The Twilight Zone.' Here's why.
Viking Stock Has Gained 254% Since Its IPO. Here's Whether That Run Is Anywhere Near Over.
The economy may be sputtering, but the luxury travel niche is not.
BlackRock® Canada Announces Final September Cash Distributions for the iShares® Premium Money Market ETF
TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc.
Finally, Some Good News for Lucid -- but There's a Catch
There's been plenty of bad news to digest for Lucid investors, but its recent partnership with Bolt in Europe is at least positive -- even if mostly hype for now.
Leon's Furniture Stock: Cash-Rich Retail Leader With an 11% Free Cash Flow Yield -- Is It a Buy for Long-Term Investors?
Key PointsThis $1.7 billion Canadian market cap company is showing strong results.